Abbott's FreeStyle Libre® 3 Receives U.S. FDA Clearance - Features World's Smallest, Thinnest and Most Accurate 14-Day Glucose Sensor Pharmaceutical Investing
Medtronic reports full year and fourth quarter fiscal year 2022 financial results; announces 8% dividend increase Medical Device Investing
INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Abbott Laboratories' Directors and Officers for Breach of Fiduciary Duties - ABT Pharmaceutical Investing
Abbott to Release EleCare® Amino Acid-based Formulas to Help Meet Critical Patient Need Pharmaceutical Investing
Applied UV Adds Veteran Leader and Banking Executive Jos Luhukay to Board of Directors Medical Device Investing
Knight Therapeutics Enters into Exclusive License and Supply Agreements with Rigel Pharmaceuticals to Commercialize Fostamatinib in Latin America Pharmaceutical Investing
Medtronic to announce financial results for its fourth quarter and full fiscal year 2022 Medical Device Investing
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies Pharmaceutical Investing
